Elderly Patients Clinical Trial
Official title:
Sequential Paclitaxel Chemotherapy and Radiotherapy as First Line Treatment for Elderly Metastatic Esophageal Squamous Cell Cancer:: a Phase II Single Center Prospective Clinical Trial
Elderly patients with metastatic esophageal squamous cell carcinomas have poor prognosis and majority of them were intolerable to combined chemotherapy in China. In the investigators phase II clinical trial proceeded before, the paclitaxel treatment showed good tolerance and efficacy to esophageal squamous cell carcinomas. Radiotherapy has been indicated as a definitive treatment for unresectable or medically inoperable tumors in ESCC patients. However, not only the combination with chemotherapy, but also the boundaries of the clinical target volume (CTV) are not internationally defined. The investigators then initiated a prospective phase II clinical trial with sequential paclitaxel/cisplatin and radiotherapy as the 1st line treatment in elderly metastatic esophageal carcinoma to observe the efficacy and safety of the combination.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | July 2016 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 69 Years and older |
Eligibility |
Inclusion Criteria: 1. Having signed informed consent Age more than 69 years old 2. Histologically confirmed esophageal squamous carcinoma,metastatic disease with primary tumor,no prior palliative chemotherapy; 3. No prior radiotherapy except radiotherapy at non-target lesion of the study more than 3 months 4. Sex is not limited 5. Measurable disease according to the RECIST criteria(diameter of the lesion should be more than 10mm by spiral CT or MRI, more than 20mm by common CT, the date of image should be less than 15 days before enrollment) 6. Karnofsky performance status =80 7. Life expectancy of = 3 month 8. WBC > 3,000/mm3, absolute neutrophil count =2000/mm3, platelet > 100,000/mm3, Hb > 9g/dl(within 14 days before enrollment),ALT and AST < 1.5 times ULN (=5 times ULN in patients with liver metastases),Bilirubin level < 1.0 times ULN,Serum AKP < 2.5 times ULN,Serum creatinine < 1.0 times ULN 9. No sever complication, such as active gastrointestinal bleeding, perforation, jaundice, obstruction, non-cancerous fever > 38?; 10. Normal ECG and heart function 11. Fertile patients must use effective contraception Good compliance Exclusion Criteria: 1. Previous treatment of palliative chemotherapy 2. Known hypersensitivity to Paclitaxel,Cisplatin 3. Only with Brain or bone metastasis 4. No measurable lesions, eg. pleural fluid and ascites 5. Suffer from severe heart disease or disease with other important organs Chronic diarrhea or renal dysfunction 6. Other previous malignancy within 5 year, except non-melanoma skin cancer 7. Mentally abnormal or disable cognition,including CNS metastasis |
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
China | Peking University Cancer Hospital | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Shen Lin |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | disease control rate | 1 year | No | |
Other | adverse events | 2 years | Yes | |
Other | quality of life | 2 years | No | |
Primary | progression free survival | the follow-up visit of PFS will be performed every 2 cycles | 1 year | No |
Secondary | overall survival | OS means that from the first dose of treatment drug to death or lost, the follow-up visit will be performed every 3 months till death or lost | 2 years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06025071 -
Residual Inflammatory Risk-Guided colcHicine in Elderly Trial
|
Phase 4 | |
Recruiting |
NCT05939674 -
Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam
|
N/A | |
Active, not recruiting |
NCT01862445 -
Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients
|
||
Completed |
NCT04065763 -
Correlation of the Dural Sac Dimension With the Spread of Spinal Anesthesia
|
||
Completed |
NCT06174168 -
The Decisiveness of MFI-11 in Predicting Complications in Patients > 65 Years Who Underwent EBUS-TBNA Under Sedation
|
||
Completed |
NCT05103696 -
A Comparative Study of Rimazolam and Propofol Combined With Etomidate in Gastroenteroscopy in Elderly Patients
|
N/A | |
Active, not recruiting |
NCT05603364 -
Effect of Postoperative Oral Carbohydrate Administration in Total Knee Arthroplasty Elderly Patients
|
Early Phase 1 | |
Terminated |
NCT03743961 -
Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia
|
||
Completed |
NCT00773942 -
Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries
|
N/A | |
Terminated |
NCT03324711 -
Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa)
|
N/A | |
Completed |
NCT03211312 -
Prediction Model of Cardiac Risk for Dental Extraction in Elderly Patients With Cardiovascular Diseases
|
||
Enrolling by invitation |
NCT04389008 -
The Study of Anesthesia-related Risk Factors for Postoperative Death in Elderly Non-cardiac Surgery Patients in China
|
||
Completed |
NCT01851005 -
Effect of Dexmedetomidine on Recovery Profiles of Elderly Patients
|
N/A | |
Recruiting |
NCT04442412 -
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
|
Phase 3 | |
Completed |
NCT02873533 -
Modification of the Quality of Life Based on Objective Geriatric Tests
|
N/A | |
Completed |
NCT01599676 -
Citrulline, Exercise Training and Muscle Strength in the Elderly
|
N/A | |
Completed |
NCT04209738 -
Changes in Cardiovascular and Sleep Quality Parameters Under Eurythmy Therapy and Tai Chi in Comparison to Standard Care - A Substudy of the ENTAiER Trial
|
||
Recruiting |
NCT04321265 -
Outcomes and Prognostic Factors in COVID-19
|
||
Recruiting |
NCT05242692 -
The Effects of Subanesthetic S-ketamine on Postoperative Delirium and Cognitive Function in the Elderly Undergoing Non-cardiac Thoracic Surgery
|
Early Phase 1 | |
Completed |
NCT03868007 -
Protective Effects of RIC in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome
|
N/A |